Deutsche Bank analyst, Esther Rajavelu, reiterated her Sell rating on shares of Ligand Pharma (NASDAQ: LGND) but raised her price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE